201 related articles for article (PubMed ID: 38168102)
1. Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming β-propeller.
Saccuzzo EG; Mebrat MD; Scelsi HF; Kim M; Ma MT; Su X; Hill SE; Rheaume E; Li R; Torres MP; Gumbart JC; Van Horn WD; Lieberman RL
Nat Commun; 2024 Jan; 15(1):155. PubMed ID: 38168102
[TBL] [Abstract][Full Text] [Related]
2. The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence.
Hill SE; Donegan RK; Lieberman RL
J Mol Biol; 2014 Feb; 426(4):921-35. PubMed ID: 24333014
[TBL] [Abstract][Full Text] [Related]
3. Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.
Patterson-Orazem AC; Hill SE; Wang Y; Dominic IM; Hall CK; Lieberman RL
Biochemistry; 2019 Apr; 58(13):1718-1727. PubMed ID: 30802039
[TBL] [Abstract][Full Text] [Related]
4. Different Grp94 components interact transiently with the myocilin olfactomedin domain in vitro to enhance or retard its amyloid aggregation.
Huard DJE; Jonke AP; Torres MP; Lieberman RL
Sci Rep; 2019 Sep; 9(1):12769. PubMed ID: 31484937
[TBL] [Abstract][Full Text] [Related]
5. The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.
Burns JN; Turnage KC; Walker CA; Lieberman RL
Biochemistry; 2011 Jul; 50(26):5824-33. PubMed ID: 21612213
[TBL] [Abstract][Full Text] [Related]
6. Calcium dysregulation potentiates wild-type myocilin misfolding: implications for glaucoma pathogenesis.
Saccuzzo EG; Martin MD; Hill KR; Ma MT; Ku Y; Lieberman RL
J Biol Inorg Chem; 2022 Sep; 27(6):553-564. PubMed ID: 35831671
[TBL] [Abstract][Full Text] [Related]
7. Molecular Insights into Myocilin and Its Glaucoma-Causing Misfolded Olfactomedin Domain Variants.
Lieberman RL; Ma MT
Acc Chem Res; 2021 May; 54(9):2205-2215. PubMed ID: 33847483
[TBL] [Abstract][Full Text] [Related]
8. Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones.
Burns JN; Orwig SD; Harris JL; Watkins JD; Vollrath D; Lieberman RL
ACS Chem Biol; 2010 May; 5(5):477-87. PubMed ID: 20334347
[TBL] [Abstract][Full Text] [Related]
9. The glaucoma-associated olfactomedin domain of myocilin is a novel calcium binding protein.
Donegan RK; Hill SE; Turnage KC; Orwig SD; Lieberman RL
J Biol Chem; 2012 Dec; 287(52):43370-7. PubMed ID: 23129764
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for misfolding in myocilin-associated glaucoma.
Donegan RK; Hill SE; Freeman DM; Nguyen E; Orwig SD; Turnage KC; Lieberman RL
Hum Mol Genet; 2015 Apr; 24(8):2111-24. PubMed ID: 25524706
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion.
Gobeil S; Letartre L; Raymond V
Exp Eye Res; 2006 Jun; 82(6):1017-29. PubMed ID: 16466712
[TBL] [Abstract][Full Text] [Related]
12. Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG).
Sharma R; Kumari A; Kundu B; Grover A
RSC Adv; 2022 Oct; 12(45):29469-29481. PubMed ID: 36320765
[TBL] [Abstract][Full Text] [Related]
13. Ligands for glaucoma-associated myocilin discovered by a generic binding assay.
Orwig SD; Chi PV; Du Y; Hill SE; Cavitt MA; Suntharalingam A; Turnage KC; Dickey CA; France S; Fu H; Lieberman RL
ACS Chem Biol; 2014 Feb; 9(2):517-25. PubMed ID: 24279319
[TBL] [Abstract][Full Text] [Related]
14. Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma.
Stothert AR; Suntharalingam A; Huard DJ; Fontaine SN; Crowley VM; Mishra S; Blagg BS; Lieberman RL; Dickey CA
Hum Mol Genet; 2014 Dec; 23(24):6470-80. PubMed ID: 25027323
[TBL] [Abstract][Full Text] [Related]
15. Quantitative differentiation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability.
Scelsi HF; Hill KR; Barlow BM; Martin MD; Lieberman RL
Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36579626
[TBL] [Abstract][Full Text] [Related]
16. Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.
Rodrigues JR; Simões CJ; Silva CG; Brito RM
Protein Sci; 2010 Feb; 19(2):202-19. PubMed ID: 19937650
[TBL] [Abstract][Full Text] [Related]
17. Amyloid fibril formation by the glaucoma-associated olfactomedin domain of myocilin.
Orwig SD; Perry CW; Kim LY; Turnage KC; Zhang R; Vollrath D; Schmidt-Krey I; Lieberman RL
J Mol Biol; 2012 Aug; 421(2-3):242-55. PubMed ID: 22197377
[TBL] [Abstract][Full Text] [Related]
18. Calcium-ligand variants of the myocilin olfactomedin propeller selected from invertebrate phyla reveal cross-talk with N-terminal blade and surface helices.
Hill SE; Cho H; Raut P; Lieberman RL
Acta Crystallogr D Struct Biol; 2019 Sep; 75(Pt 9):817-824. PubMed ID: 31478904
[TBL] [Abstract][Full Text] [Related]
19. Biophysical characterization of the olfactomedin domain of myocilin, an extracellular matrix protein implicated in inherited forms of glaucoma.
Orwig SD; Lieberman RL
PLoS One; 2011 Jan; 6(1):e16347. PubMed ID: 21283635
[TBL] [Abstract][Full Text] [Related]
20. Molecular Details of Olfactomedin Domains Provide Pathway to Structure-Function Studies.
Hill SE; Donegan RK; Nguyen E; Desai TM; Lieberman RL
PLoS One; 2015; 10(6):e0130888. PubMed ID: 26121352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
